FLUCONAZOLE-RESISTANT AND ITRACONAZOLE-RESISTANT CANDIDA-ALBICANS STRAINS FROM AIDS PATIENTS - MULTILOCUS ENZYME ELECTROPHORESIS ANALYSIS AND ANTIFUNGAL SUSCEPTIBILITIES

被引:64
作者
LEGUENNEC, R
REYNES, J
MALLIE, M
PUJOL, C
JANBON, F
BASTIDE, JM
机构
[1] FAC PHARM MONTPELLIER, IMMUNOL & PARASITOL LAB, F-34060 MONTPELLIER 1, FRANCE
[2] CHU MONTPELLIER, HOP GUI CHAULIAC, SERV MALAD INFECT & TROP, F-34295 MONTPELLIER 5, FRANCE
关键词
D O I
10.1128/JCM.33.10.2732-2737.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Multilocus enzyme electrophoresis and in vitro susceptibility testing with a broth microdilution method were used to analyze Candida albicans strain diversity in four AIDS patients with recurrent oropharyngeal candidiasis who successively developed clinical resistance to fluconazole (FCZ) and itraconazole (ITZ). One to ten colonies per sample were randomly chosen from oral washings collected before the initial FCZ treatment and just before every other antifungal treatment; a total of 98 isolates were analyzed. Multilocus enzyme electrophoresis analysis revealed 14 different electrophoretic types (ETs). Statistical analysis of genetic distances showed that C. albicans isolates clustered into five subpopulations (I to V). In each subpopulation, isolates are closely related, and genetic distances between subpopulations I to V are short. In contrast, subpopulation V, which contained isolates typed as ET8 and ET14 is strongly divergent from the others; these isolates may represent atypical C. albicans isolates. Only one patient was infected with a single strain during the course of azole therapy; for the three remaining patients, variants of the same strain and different strains were concurrently isolated. Clinical FCZ resistance was clearly correlated with in vitro data for three patients. Moreover, MICs of ITZ increased during FCZ therapy, and MICs of ITZ which were greater than or equal to 1.56 mu g/ml were found when clinical ITZ resistance occurred; isolates from subpopulation V showed the highest MICs of ITZ. Because of the emergence of clinical ITZ resistance after clinical FCZ resistance, the feasibility of long-term azole therapy for mucosal candidiasis in AIDS patients is questioned.
引用
收藏
页码:2732 / 2737
页数:6
相关论文
共 33 条
[31]  
VANDENBOSSCHE H, 1990, BIOCHEM SOC T, V18, P56
[32]   CHARACTERIZATION OF AN AZOLE-RESISTANT CANDIDA-GLABRATA ISOLATE [J].
VANDENBOSSCHE, H ;
MARICHAL, P ;
ODDS, FC ;
LEJEUNE, L ;
COENE, MC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (12) :2602-2610
[33]   DEFECTIVE STEROL C5-6 DESATURATION AND AZOLE RESISTANCE - A NEW HYPOTHESIS FOR THE MODE OF ACTION OF AZOLE ANTIFUNGALS [J].
WATSON, PF ;
ROSE, ME ;
ELLIS, SW ;
ENGLAND, H ;
KELLY, SL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 164 (03) :1170-1175